Author

Shinichiro Yamada

Nagoya UniversityORCID 0000-0002-6523-9288Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Assay:metabolomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Gen SobueiD· 2 shared Masahisa KatsunoiD· 2 shared Akinobu OtaiD· 1 shared Atsushi HashizumeiD· 1 shared Daisuke ItoiD· 1 shared Daisuke Shimojo· 1 shared Hideyuki OkanoiD· 1 shared Hyeon‐Cheol LeeiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Gen SobueORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Early pathogenesis of spinal and bulbar muscular atrophy uncovered by human iPSC-derived motor neurons highlights pathogenic neuropeptides as therapeutic targets

Kazunari Onodera, Yuichi Riku, Daisuke Shimojo, Akinobu Ota, Muhammad Irfanur Rashid, Rina Okada, Shinichi Yamaguchi, Shinichiro Yamada, Yoshitaka Hosokawa, Mari Yoshida, Yasushi Iwasaki, Manabu Doyu, Gen Sobue, Masahisa Katsuno, Hideyuki Okano, Yohei Okada

The paper uses human iPSC-derived motor neurons to study SBMA, identifying neuropeptides as therapeutic targets.

bioRxiv · Dec 13, 2025 · PreprintNeuroscience

Dysregulated expanded endocannabinoid system as therapeutic targets of amyotrophic lateral sclerosis

Daisuke Ito, Madoka Iida, Yohei Iguchi, Atsushi Hashizume, Shinichiro Yamada, Yoshiyuki Kishimoto, Shota Komori, Teppei Shimamura, Yuto Takemoto, Masahiro Nakatochi, Tomohiro Akashi, Kunihiko Hinohara, Hyeon‐Cheol Lee, Jun‐ichi Niwa, Gen Sobue, , Masahisa Katsuno

The paper identifies dysregulated expanded endocannabinoid system metabolites in ALS and shows FAAH inhibition improves motor neuron degeneration in models.

bioRxiv · Jan 12, 2024 · PreprintNeuroscience